Search research articles
Contact Us
Filters
Showing results (61-70 of 125) with videos related to
Page
of 13
Sort By:
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
October 2, 2007
Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera
Robert W Evans, Roozina Rafique, Adel Zarea, et al.
British Journal of Haematology
|
September 22, 2009
Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload
Ali Taher, Maria D Cappellini, Elliott Vichinsky, et al.
American Journal of Hematology
|
October 2, 2023
Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia
Maciej W Garbowski, Manuel Ugidos, Alberto Risueño, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
June 12, 2014
Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan
Maciej W Garbowski, John-Paul Carpenter, Gillian Smith, et al.
Hemasphere
|
November 21, 2022
Untreated Anemia in Nontransfusion-dependent β-thalassemia: Time to Sound the Alarm
Khaled M Musallam, Ali T Taher, Maria Domenica Cappellini, et al.
European Journal of Haematology
|
November 19, 2016
Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia
John B Porter, Mohsen Elalfy, Ali Taher, et al.
Blood Transfusion = Trasfusione Del Sangue
|
August 9, 2012
Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias
Vip Viprakasit, Norbert Gattermann, Jong Wook Lee, et al.
European Journal of Haematology
|
June 9, 2011
Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias
John B Porter, Kai-Hsin Lin, Photis Beris, et al.
British Journal of Haematology
|
October 20, 2004
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance
Lisa J Anderson, Mark A Westwood, Sally Holden, et al.
Blood
|
June 23, 2010
Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial
Jong Wook Lee, Sung-Soo Yoon, Zhi Xiang Shen, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 125) with videos related to
Sort By:
Page
of 13
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
October 2, 2007
Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera
Robert W Evans, Roozina Rafique, Adel Zarea, et al.
British Journal of Haematology
|
September 22, 2009
Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload
Ali Taher, Maria D Cappellini, Elliott Vichinsky, et al.
American Journal of Hematology
|
October 2, 2023
Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia
Maciej W Garbowski, Manuel Ugidos, Alberto Risueño, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
June 12, 2014
Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan
Maciej W Garbowski, John-Paul Carpenter, Gillian Smith, et al.
Hemasphere
|
November 21, 2022
Untreated Anemia in Nontransfusion-dependent β-thalassemia: Time to Sound the Alarm
Khaled M Musallam, Ali T Taher, Maria Domenica Cappellini, et al.
European Journal of Haematology
|
November 19, 2016
Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia
John B Porter, Mohsen Elalfy, Ali Taher, et al.
Blood Transfusion = Trasfusione Del Sangue
|
August 9, 2012
Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias
Vip Viprakasit, Norbert Gattermann, Jong Wook Lee, et al.
European Journal of Haematology
|
June 9, 2011
Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias
John B Porter, Kai-Hsin Lin, Photis Beris, et al.
British Journal of Haematology
|
October 20, 2004
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance
Lisa J Anderson, Mark A Westwood, Sally Holden, et al.
Blood
|
June 23, 2010
Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial
Jong Wook Lee, Sung-Soo Yoon, Zhi Xiang Shen, et al.
Page
of 13